AH1N1 Vaccine
Testing In Costa Rica Ends, Results Expected
In 30 Days
The results of the AH1N1 vaccine tests are
expected to be available within the next 30
days now that the trial phase has ended. A
total 784 Costa Ricans took part in the
trials held at the Instituto de Atención
Pediátrica (IAP).
The group made up of adults and children
between the ages of 3 and 64 were given a
dose of the vaccine produced by the Swiss
pharmaceutical, Novartis, one of six which
is working on a vaccine for the AH1N1.
Health officials say that the side effects
of the vaccine have been minor and within a
month the body could begin to generate
antibodies against the AH1N1.
In Costa Rica the number of deaths from the
AH1N1 flu virus is 33. A total of 1.115
cases have been confirmed, with the majority
of the new confirmed cases being centred in
Pérez Zeledón, Limón and Puntarenas.
|
|
|
|
|
| |
|
|
|
|
|
